VIVUS, Inc. (VVUS): An Obese Proxy Fight
Proxy fights are like the demolition derby of the investment world.
Posts Tagged ‘Biogen Idec Inc (BIIB)’
Alexion Pharmaceuticals, Inc. (ALXN), Harman International Industries Inc./DE/ (HAR): Today’s 3 Best Stocks
Under normal circumstances, the markets would sell off on news that the U.S. Commerce Department made a downward revision to its final first-quarter GDP growth figure.
Amgen, Inc. (AMGN): The Only True Biotech Dividend Stock
Dividend stocks are hard to come by in the biotech space.
Biogen Idec Inc (BIIB), BlackRock, Inc. (BLK): Picks and Pans for the Pullback
The U.S. stock market is down around 6%, Treasuries are getting crushed, bond funds are down, and gold is down.
Time to Buy Amgen, Inc. (AMGN)?
A double-digit drop for Amgen, Inc. (NASDAQ:AMGN) stock over the past couple of months has likely left a bad taste in the mouths of shareholders.
Biogen Idec Inc. (BIIB), Alexion Pharmaceuticals, Inc. (ALXN): Best-Run Biotech Companies
Which biotech companies are the best-run? That could be a difficult question to answer, since there are many perspectives on what constitutes a well-run company.
Is Elan Corporation, plc (ADR) (ELN) Pushing Its Luck?
Recently Elan Corporation, plc (ADR) (NYSE:ELN)'s shareholders voted against management's proposal to invest $1 billion in Theravance Inc (NASDAQ:THRX), a deal which a fellow...
Biogen Idec Inc. (BIIB): Elan Corporation, plc (ADR) (ELN) Likely To Receive Higher Takeout Bids
Elan Corporation, plc (ADR) (NYSE:ELN) has been in the news over the past few months because of a hotly contested battle with Royalty Pharma. The battle began on Feb.
Gilead Sciences, Inc. (GILD), American International Group, Inc. (AIG): The Biggest Companies That Don’t Pay Dividends — But May Be About To
The S&P 500 fell nearly 10% in June 2008, and investors began to brace for an eventual market crash later in the year.
Biogen Idec Inc. (BIIB), Sanofi SA (ADR) (SNY): A Must Have Pharma Stock
After a year-long dream run, Biogen Idec Inc. (NASDAQ:BIIB) lost 5.25% in the week ended Friday, June 7.
Biotechs Lose Ground As Achillion Pharmaceuticals, Inc. (ACHN) Takes a Dive
Biotechnology's a volatile sector that can intimidate many investors, but it's also a landscape of stocks that can reward portfolios with giant gains.
First Solar, Inc. (FSLR), Biogen Idec Inc. (BIIB), Electronic Arts Inc. (EA): Today’s Three Worst Stocks
It's been a tough week for equities.
Biogen Idec Inc. (BIIB): Will This Company Dominate the Multiple Sclerosis Market?
With one product already on the market, one recently approved and four more in various stages of clinical development, Biogen Idec Inc.
Biogen Idec Inc. (BIIB), salesforce.com, inc. (CRM): Today’s 3 Worst Stocks
If you somehow glossed over the title of this article, then skipped this paragraph and simply read about the following three stocks without any context, you might think that today...
Omthera Pharmaceuticals Inc (OMTH), GlaxoSmithKline plc (ADR) (GSK): This Week in Biotech
With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Where to Invest for More Health-Care Exposure
You have plenty of choices of where to invest your portfolio.
Do Hedge Funds and Insiders Love Celgene Corporation (CELG)?
Celgene Corporation (NASDAQ:CELG) was in 44 hedge funds' portfolio at the end of the first quarter of 2013.
Amgen, Inc. (AMGN) Stock Checkup for May
I have jokingly referred to Amgen, Inc. (NASDAQ:AMGN) in the past as a "senior citizen" of biotech. The company was founded 33 years ago, making Amgen, Inc.
PDL BioPharma Inc. (PDLI), AbbVie Inc (ABBV): Two Scariest Dividend Stocks in Health Care
Combining nice dividends with a growing industry that comprises roughly one-fifth of the nation's GDP should make for an attractive stock -- in theory.
Visa Inc (V), Alliance Data Systems Corporation (ADS) & More: Navellier & Associates’ Top Portfolio Holdings
With roughly $2.5bn in assets under management, Navellier & Associates is a team of about twelve investment professionals that use quantitative and fundamental analysis to employ...
Celgene Corporation (CELG), Biogen Idec Inc. (BIIB), Gilead Sciences, Inc. (GILD): Don’t Try to Pick the Best Biotech Company
Rising biotech stars Celgene Corporation (NASDAQ:CELG), Biogen Idec Inc. (NASDAQ:BIIB), and Gilead Sciences, Inc.
Biogen Idec Inc. (BIIB) Bounces Higher
If you thought that the great run so far in 2013 was over for Biogen Idec Inc. (NASDAQ:BIIB), think again.
Johnson & Johnson (JNJ): Buying Isn’t for Growth Investors
If there's one health-care stock every investor knows by name, it's Johnson & Johnson (NYSE:JNJ).
Gilead Sciences, Inc. (GILD) or Biogen Idec Inc. (BIIB)? This Is What the Perfect Biotech Would Look Like
I don't know about you, but I'm pretty stoked for the NFL draft this Thursday.
Eli Lilly & Co. (LLY), WellPoint, Inc. (WLP) & Five Must-Watch Earnings Reports in the Health-Care Sector This Week
If you haven't noticed, it's earnings season once again! Believe it or not, there are times when earnings reports slow down in frequency, but this is certainly not one of those...
Why Elan Corporation, plc (ADR) (ELN) Shouldn’t Take Royalty Pharma’s Sweetened Bid
After years of being plagued by a waning stock price, FDA regulatory issues and safety concerns over its blockbuster drug, its finally good to be Elan Corporation, plc (ADR) (...
Biogen Idec Inc. (BIIB), Pharmacyclics, Inc. (PCYC), Immunomedics, Inc. (IMMU), and Tackling Cancer, Non-Hodgkin Lymphoma’s Biggest Current & Upcoming Players
As I noted seven weeks ago, cancer statistics are both staggering and disappointing.
Under The Hood: An Unheralded Biotech ETF – iShares NASDAQ Biotechnology Index (IBB)
Another day, another set of fresh all-time highs for the major biotechnology ETFs.
Arena Pharmaceuticals, Inc. (ARNA), Biogen Idec Inc. (BIIB): More Than an Obesity Drug Company
Arena Pharmaceuticals, Inc.
Amgen, Inc. (AMGN): The One Biotech Stock Buffett Should Buy
The biotechnology sector can be a land of immense spoils and incredible heartbreak.
Johnson & Johnson (JNJ), Rigel Pharmaceuticals, Inc. (RIGL): This Week in Biotech
With the SPDR S&P Biotech Index up 22% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Medivation Inc (MDVN), Amarin Corporation plc (ADR) (AMRN), Abbott Laboratories (ABT): Adage Capital Management Owns 5.4% of This Company
According to a 13G filed with the SEC, Adage Capital Management, a large hedge fund managed by Phil Gross and Robert Atchinson, owns just over 4 million shares of Medivation Inc...
Biogen Idec Inc. (BIIB), United Therapeutics Corporation (UTHR), Repros Therapeutics Inc (RPRX): This Week in Biotech
With the SPDR S&P Biotech (ETF) (NYSEARCA:XBI) Index up 25% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector...
Biogen Idec Inc. (BIIB), Sanofi SA (ADR) (SNY), Elan Corporation, plc (ADR) (ELN): The Greatest Thing Since Sliced Bread Has Arrived for MS Patients
Last November, I examined five experimental drugs that appeared as if they had all of the tools necessary to become life-changing blockbusters from a financial and quality of ...
Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Is Amgen, Inc. (AMGN) a Cash King?
In this series, we'll highlight four companies in an industry, and compare their "cash king margins" over time, trying to determine which has the greatest likelihood of putting...
Abbott Laboratories (ABT), Biogen Idec Inc. (BIIB): Will Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Help You Retire Rich?
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.
Pfizer Inc. (PFE), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Decision Looms on New Multiple Sclerosis Drug
Will good news from Europe echo on this side of the Atlantic within the next few days? Biogen Idec Inc. (NASDAQ:BIIB) is certainly hoping so.
Better Biotech Buy: Biogen Idec Inc. (BIIB) vs. Celgene Corporation (CELG)
Buying big pharma stocks isn't the only way you can invest in today's best-selling drugs without taking a gamble on a small, risky biotech.
The Fight Over This Biotech’s Cash: Elan Corporation, plc (ADR) (ELN)
Elan Corporation, plc (ADR) (NYSE:ELN) was nice enough to give us a little more detail on what it plans to do with the $3.25 million that the biotech stands to get from Biogen...
Elan Corporation, plc (ADR) (ELN) Received Buyout Bid Before Buyback
When Elan Corporation, plc (ADR) (NYSE:ELN) sold its stake in the blockbuster selling multiple sclerosis drug Tysabri to partner Biogen Idec Inc.
Caterpillar Inc. (CAT)’s Earnings Weigh Down the Dow
Seems like every day now the Dow Jones Industrial Average is touching a new yearly high. As of 2:25 p.m.
Biogen Idec Inc. (BIIB): A Strong Growth Opportunity In Multiple Sclerosis
Biogen Idec Inc.(NASDAQ:BIIB) has just moved to reinforce its dominance in the multiple sclerosis treatment market by striking a deal to buy the 50% rights to Tysabri that it...
Spectrum Pharmaceuticals, Inc. (SPPI) Earnings: An Early Look
Earnings season is now starting to wind down, with most companies already having reported their quarterly results.
Celgene Corporation (CELG): My Favorite Big Biotech for 2013
The biggest biopharmaceutical companies blazed trails and lifted portfolios last year.
Amgen, Inc. (AMGN)’s Future Is Brighter Than You Might Think
When you think about a cutting-edge, one-foot-in-the-future biotech company, no one would blame you for skipping over Amgen, Inc. (NASDAQ:AMGN).
Will Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Rule This Multibillion-Dollar Market?
Back in 2011, generic drug giant Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) dominated the MS field, riding the coattails of its Copaxone medication to success.
Why Elan Corporation, plc (ELN) Cut Its Ties To Tysabri
Elan Corporation, plc (NYSE:ELN) just announced a restructuring of its Tysabri collaboration with Biogen Idec Inc.
